We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Esure | LSE:ESUR | London | Ordinary Share | GB00B8KJH563 | ORD 1/12P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 279.60 | 279.40 | 279.80 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/3/2015 10:59 | The price is right because that's what the shares are worth on the open market. Doesn't matter what analysts think. Most of the time you can find totally oposite views. You buy and sell at the prevailing price and the divi just doesn't do it for me. For me its a bit of gamling and as long as my financial advisor keeps getting me 20% anual return it will stay that way. | bikeaholic | |
12/3/2015 08:51 | Can't see a bid, Wood holds too many to make an offer - least of all by a company he had previously set up. Think it will drift a bit lower in the next couple of weeks then pick up a bit towards the xd date. Most broker targets still seem to be around the 250 level. I think the company is well run, its a case of waiting for the market to harden - how long this will take is anyones guess. | dr biotech | |
12/3/2015 08:22 | This is just too weak as though it is desperate to hit 200p sooner... | diku | |
11/3/2015 22:04 | Anybody think DLG could be looking in here?... | diku | |
11/3/2015 17:19 | Well Invesco generally know what they are doing, and I think they fit into the general description of a "big boy". So the share price is right today, and will be right in a few weeks too.... | redsonning | |
10/3/2015 23:41 | Having shaken away some of the shareholders who fail to understand what investment and good management are about, Esure will soon start to be bid back up by the big boys who understand that this is one of the best managed companies in the sector. Even in difficult times they have produced remarkably good figures and have a very sound structure. Dividend is extremely strong and prospects for improvement from this base will be hard to resist. So I expect to see upward movement as we head towards the ex-dividend date. And by the way, of course the share price is always right. So it was right when the price was 230+ and then it was right when it was 20 pence lower just a matter of minutes later. Investment management is all about timing, and sometimes one has to work out why share prices are doing what they do in order to take best advantage of situations. | redsonning | |
10/3/2015 22:13 | Share price is never always right!!...its one giant casino controlled by the computers...brings back memories of tech boom & bust!... | diku | |
10/3/2015 14:34 | The share price is always right, everything else is hope or an attempt to justify bad advise. | bikeaholic | |
10/3/2015 13:23 | Doubt the downgrade will have helped. I think its a good bet for the next 2-3 years assuming that the market picks up at some point. Just have to ignore the share price and think of the dividend. | dr biotech | |
10/3/2015 13:03 | The share price has fallen out of bed and yet the analysts still seem positive on this share. So who is right? 10 Mar JP Morgan... 290.00 Overweight 10 Mar Deutsche Bank 255.00 Hold 9 Mar Deutsche Bank 275.00 Buy | grevis | |
10/3/2015 13:00 | JP Morgan Cazenove Overweight 211.20 290.00 290.00 Reiterates Deutsche Bank Hold 211.20 275.00 255.00 Downgrades | skinny | |
10/3/2015 09:34 | Thats some drop and recovery this morning. Hard to see why they are were so badly hit. Perhaps its the forward looking comments about claims inflation affecting the future COR. I hold these for the yield - have to doubt whether the payout ration of 85% is sustainable. | dr biotech | |
10/3/2015 09:09 | wow, that was a bit of a shake-out! | kazuko | |
10/3/2015 09:04 | Excellent results - well managed company. | redsonning | |
10/3/2015 08:23 | I Have,, hoping for a short term drop | tony773 | |
10/3/2015 08:21 | Rather surprising price action here given the reaction to rather underwhelming results at Admiral. If I didn't own the non life insurer Lancashire which yields over 10% with its constant stream of huge special divis I would be tempted to take some here. | salpara111 | |
10/3/2015 07:24 | Current PER at yesterdays closing price is circa 12 with a yield of 7.1%. Solid hold for me. | masurenguy | |
10/3/2015 07:09 | Solid results achieved through a disciplined approach in a challenging environment Headlines · In-force policies up 0.7% to 1.946 million (2013: 1.933 million) · Gross written premiums down 3.4% to £517.8 million (2013: £535.8 million) · Profit before tax down 12.8% to £103.3 million (2013: £118.4 million) impacted by current market conditions and costs associated with the acquisition of Gocompare1 · Combined operating ratio2 increased by 2.2ppts to 91.9% (2013: 89.7%) · Additional Services Revenue ("ASR")3 broadly flat at £103.0 million (2013: £103.9 million) - ASR excluding Claims Income3 up 1.7% to £97.3 million (2013: £95.7 million) · Pro forma earnings per share4 down 11.6% to 19.8 pence (2013: 22.4 pence) · Final dividend of 11.7 pence per share (2013: 13.3 pence). Full year dividend of 16.8 pence per share (2013: 15.8 pence) represents a payout ratio of 85%. The payout ratio comprises a base dividend of 50% and a special dividend of 35%. · Strong financial position with IGD5 coverage of 377% after the final dividend · Acquisition of the outstanding 50% of Gocompare1 for £95.0 million; expected to complete on 31 March 2015, funded by the issue of £125.0 million 6.75% ten year tier two Subordinated Notes | skinny | |
03/3/2015 09:50 | Results at direct line were well received this morning. Lets hope we can follow them. | dr biotech | |
27/2/2015 15:36 | Glad to hear they are charging high prices - that's exactly what I want to hear as a shareholder. | redsonning | |
27/2/2015 14:51 | renew - Next time don't offer them a chance to have your wife - you might get a better quote. :-))) | lord gnome | |
27/2/2015 13:10 | How do these guys get any business!!! As I have a shed load of these shares thought I would give them a chance to have my wife and my car insurance.Both retired, donkeys years of no claims. quote 20% higher than my renewal from Churchill. Cant even get a quote without putting in a fictitious "how you heard of them" Beginning to question why I own so many of these. | renew | |
19/2/2015 21:33 | Very unusual tight price action today... | diku | |
12/2/2015 15:21 | One can never tell what these brokers agenda is inorder to make quick easy buck....City thrives on that.... | diku |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |